Women’s health is an area of medicine that has historically been under-researched and under-funded. However, there has been growing recognition of the unmet need for research and treatments in this field. Microbiome research has shown promise in addressing some of these unmet needs.

From the vaginal microbiome in reproductive health to the impact of menopause on the skin microbiome, the applications of microbiome science in women’s health are wide reaching and present an opportunity to develop novel therapeutic approaches and diagnostics.

Following the successfull inaugral event in Copenhagen in April 2024 which sold out attracting +200 attendees, the second edition of “Microbiomes in Women’s Health Congress” takes place in Amsterdam on 9-10 April 2025 taking it one step further: +300 world-leading microbiome researchers, cutting-edge biotechs, and healthcare and pharmaceutical voices will unite once more to present their work on how the microbiome can be used to improve women’s health.

The event will be split into chronological stages across a woman’s life spanning sessions on: exploring what is a typical vaginal microbiome, fertility, pregnancy, menopause, women-specific indications, and the development of therapeutics.